RECRUITING

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

Talk to us

Conditions

X-linked HypophosphatemiaGene MutationBone DiseaseMetabolic DiseaseMusculoskeletal Disease,Rare DiseaseHypophosphatemiaFamilial Renal Tubular TransportInborn ErrorsKidney Diseases

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.

Official Title

A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients With X-linked Hypophosphatemia

Quick Facts

Study Start:2024-10-09
Study Completion:2028-05-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06525636

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Part 1:
  1. * Part 1:

Contacts and Locations

Study Contact

Kyowa Kirin
CONTACT
609-919-1100
KKD.Clintrial.82@kyowakirin.com

Principal Investigator

Kyowa Kirin
STUDY_CHAIR
Kyowa Kirin, Inc.

Study Locations (Sites)

University of California - San Francisco
San Francisco, California, 94115
United States
Yale School of Medicine
New Haven, Connecticut, 06510
United States
Indiana University School of Medicine University Hospital
Indianapolis, Indiana, 46202
United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232
United States

Collaborators and Investigators

Sponsor: Kyowa Kirin, Inc.

  • Kyowa Kirin, STUDY_CHAIR, Kyowa Kirin, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-09
Study Completion Date2028-05-10

Study Record Updates

Study Start Date2024-10-09
Study Completion Date2028-05-10

Terms related to this study

Keywords Provided by Researchers

  • Gene Mutation
  • Bone Disease
  • Metabolic Disease
  • Musculoskeletal Disease,
  • Rare Disease
  • Hypophosphatemia
  • Familial Renal Tubular Transport
  • Inborn Errors
  • Kidney Diseases

Additional Relevant MeSH Terms

  • X-linked Hypophosphatemia